Nalaganje...
Microbial therapeutics: New opportunities for drug delivery
With >40 clinical trials underway, we are nearing the first FDA-approved live microbial therapeutic. Here, Giovanni Traverso, MIT and Harvard Medical School Assistant Professor, and colleagues Miguel Jimenez and Institute Professor Robert Langer from MIT discuss the significant challenges of admi...
Shranjeno v:
| izdano v: | J Exp Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Rockefeller University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504217/ https://ncbi.nlm.nih.gov/pubmed/31028093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20190609 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|